SANTIN, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 1.146
EU - Europa 321
AS - Asia 206
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 1.677
Nazione #
US - Stati Uniti d'America 1.138
CN - Cina 144
UA - Ucraina 102
DE - Germania 68
IT - Italia 57
FI - Finlandia 36
HK - Hong Kong 34
SG - Singapore 22
IE - Irlanda 17
GB - Regno Unito 15
SE - Svezia 14
FR - Francia 10
CA - Canada 8
EU - Europa 3
IN - India 2
AU - Australia 1
CZ - Repubblica Ceca 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
Totale 1.677
Città #
Fairfield 170
Woodbridge 167
Ashburn 86
Houston 82
Jacksonville 74
Ann Arbor 71
Seattle 69
Wilmington 67
Cambridge 63
Dearborn 51
Chandler 34
Hong Kong 34
New York 34
Princeton 32
Nanjing 25
Helsinki 22
Shanghai 18
Dublin 17
Nanchang 12
Shenyang 11
Beijing 10
Jinan 10
Singapore 10
Brescia 9
Toronto 8
Hebei 7
Kunming 7
Milan 7
Tianjin 7
Des Moines 6
Monmouth Junction 6
San Diego 6
Jiaxing 5
Cazzago San Martino 4
Changsha 4
Hefei 4
Lanzhou 4
London 4
Arezzo 3
Hangzhou 3
Leawood 3
Ningbo 3
San Francisco 3
Los Angeles 2
Norwalk 2
Rome 2
Taiyuan 2
Zhengzhou 2
Almaty 1
Augusta 1
Bishkek 1
Boardman 1
Chengdu 1
Chicago 1
Colombo 1
Fuzhou 1
Guangzhou 1
Gunzenhausen 1
Haikou 1
Hounslow 1
Melbourne 1
Munich 1
New Bedfont 1
Olomouc 1
Paris 1
Redmond 1
Redwood City 1
Riyadh 1
San Mateo 1
Verona 1
Wuhan 1
Xian 1
Zhangzhou 1
Totale 1.307
Nome #
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 136
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes 134
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 127
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 125
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 119
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 118
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 114
Mammaglobin B expression in human endometrial cancer 113
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 107
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 105
Prognostic Significance of Vascular Endothelial Growth Factor Serum Determination in Women with Ovarian Cancer 103
Racial differences in overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in Uterine Serous Papillary Cancer 97
Claudin-7 expression in human epithelial ovarian cancer 86
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 75
Treatment of Chemotherapy-Resistant Human Ovarian Cancer Xenografts in C.B-17/SCID Mice by Intraperitoneal Administration of Clostridium Perfringens Enterotoxin (CPE). 57
Recognition of a cervical cancer derived tumor cell line by a human papillomavirus type 16 E6 52-61-specific CD8 T cell 54
Integrated mutational landscape analysis of uterine leiomyosarcomas 26
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 17
Immunogenic gangliosides in human ovarian carcinoma 1
Totale 1.714
Categoria #
all - tutte 7.312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.312


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020484 61 16 16 55 30 75 70 52 36 47 3 23
2020/2021251 3 36 1 41 8 33 18 27 31 18 28 7
2021/2022174 24 26 3 5 0 15 9 11 4 30 18 29
2022/2023134 30 4 6 1 13 22 5 12 16 2 9 14
2023/2024199 17 10 19 19 9 45 7 6 36 3 4 24
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 1.714